Related Experiment Videos
Assessing the residual effects of hypnotics
1Human Psychopharmacology Research Unit, University of Surrey, Milford Hospital, Godalming, U.K.
Acta Psychiatrica Belgica
|March 1, 1994
Summary
Novel hypnotics like zopiclone and zolpidem offer improved sleep without next-day cognitive impairment. These drugs are safer alternatives for patients with sleep disorders, enhancing daily life quality.
Area of Science:
- Pharmacology
- Sleep Medicine
- Geriatric Medicine
Background:
- Traditional hypnotics may cause residual next-day effects, including cognitive impairment and sedation.
- These 'hangover' effects negatively impact patients' quality of life, especially in older adults.
- Assessing therapeutic efficacy requires considering factors beyond sleep induction, such as morning-after performance.
Purpose of the Study:
- To compare the residual effects of novel hypnotics (zopiclone, zolpidem) with older benzodiazepines.
- To evaluate the impact of these hypnotics on next-day cognitive function, reaction time, and memory.
- To determine the potential benefits and safety of zopiclone and zolpidem for patients with sleep disorders.
Main Methods:
- Comparative analysis of drug effects.
- Cognitive, reaction time, and memory testing post-ingestion.
- Clinical assessment of patient quality of life.
Main Results:
- Zopiclone and zolpidem demonstrated superiority over older benzodiazepines.
- Novel hypnotics did not impair performance on tests of cognition, reaction time, and memory the following day.
- Older hypnotics were associated with significant residual 'hangover' effects.
Conclusions:
- Zopiclone and zolpidem represent safer and more effective hypnotic options.
- These novel compounds minimize residual next-day impairment, improving patient quality of life.
- They are beneficial for individuals with sleep disorders who need to maintain daily functioning.